argenx

ISIN US04016X1019

 | 

WKN A2H9WD

Market cap (in EUR)
43,380 m
Country
Netherlands
Sector
Healthcare
Dividend yield
0.00%
 

Overview

Description

argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands.
Show more Show less
Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals Netherlands

Financials

Key metrics

Market capitalisation, EUR 43,380 m
EPS, EUR -
P/B ratio 6.9
P/E ratio 38.6
Dividend yield 0.00%

Income statement (2025)

Revenue, EUR 3,693 m
Net income, EUR 1,149 m
Profit margin 31.11%

What ETF is argenx in?

There are 26 ETFs which contain argenx. All of these ETFs are listed in the table below. The ETF with the largest weighting of argenx is the First Trust NYSE Arca Biotechnology UCITS ETF Acc.
ETF Weight Investment focus Fund size (in m EUR)
Amundi Prime Global UCITS ETF Acc 0.06%
Equity
World
1,864
WisdomTree BioRevolution UCITS ETF USD Acc 0.91%
Equity
World
Health Care
Social/Environmental
Biotech
12
Amundi Prime Global UCITS ETF Dist 0.06%
Equity
World
1,548
L&G Gerd Kommer Multifactor Equity UCITS ETF USD Distributing 0.01%
Equity
World
Multi-Factor Strategy
197
Goldman Sachs Paris-Aligned Climate World Equity UCITS ETF USD (Acc) 0.10%
Equity
World
Social/Environmental
Climate Change
8
Xtrackers EMU Net Zero Pathway Paris Aligned UCITS ETF 1C 1.05%
Equity
Europe
Social/Environmental
Climate Change
9
Amundi Prime All Country World UCITS ETF Acc 0.05%
Equity
World
1,721
L&G Global Equity UCITS ETF 0.06%
Equity
World
Social/Environmental
1,218
Amundi Prime All Country World UCITS ETF Dist 0.05%
Equity
World
3,999
WisdomTree Megatrends UCITS ETF USD 0.10%
Equity
World
Social/Environmental
Innovation
50
Xtrackers World Net Zero Pathway Paris Aligned UCITS ETF 1C 0.09%
Equity
World
Social/Environmental
Climate Change
117
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C 3.18%
Equity
World
Health Care
Social/Environmental
Innovation
7
First Trust NYSE Arca Biotechnology UCITS ETF Acc 3.28%
Equity
United States
Health Care
Biotech
11
Invesco Nasdaq Next Generation 100 UCITS ETF Acc 1.05%
Equity
United States
39
Amundi Prime Europe UCITS ETF DR (D) 0.33%
Equity
Europe
236
Xtrackers Global Growth Leaders Active UCITS ETF 1C 1.11%
Equity
World
Growth
Moat
5
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) 1.66%
Equity
United States
Health Care
Biotech
46
L&G Gerd Kommer Multifactor Equity UCITS ETF USD Accumulating 0.01%
Equity
World
Multi-Factor Strategy
1,160
iShares Nasdaq US Biotechnology UCITS ETF 1.66%
Equity
United States
Health Care
Biotech
710
L&G Europe ex UK Equity UCITS ETF 0.44%
Equity
Europe
Social/Environmental
943
Amundi Prime Eurozone UCITS ETF DR (C) 0.64%
Equity
Europe
93
Amundi Prime Eurozone UCITS ETF DR (D) 0.64%
Equity
Europe
75
Xtrackers Europe Net Zero Pathway Paris Aligned UCITS ETF 1C 0.50%
Equity
Europe
Social/Environmental
Climate Change
6
WisdomTree Tech Megatrends UCITS ETF USD Acc 0.31%
Equity
World
Technology
Social/Environmental
Innovation
6
L&G Pharma Breakthrough UCITS ETF 2.62%
Equity
World
Health Care
Innovation
16
Amundi Prime Europe UCITS ETF DR (C) 0.33%
Equity
Europe
206
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.